Insights

Strong R&D Focus Lundbeck's dedicated emphasis on neuroscience and development of transformative brain disorder treatments presents significant opportunities for partnerships in research collaborations and supply chain solutions tailored to neuro-innovations.

Global Market Presence With products available in over 80 countries and more than 5,000 employees worldwide, Lundbeck offers a broad international partnership landscape, ideal for expanding distribution, logistics, and localized marketing initiatives.

Innovative Pipeline Recent advances like the FDA Fast Track designation for lead drugs and active pipeline presentations suggest ongoing growth; sales efforts can be aligned with their portfolio expansion in neuro-rare and neuro-specialty areas.

Strategic Acquisitions The recent $2.6 billion acquisition of Longboard Pharmaceuticals indicates Lundbeck's openness to mergers and acquisitions, providing opportunities for strategic collaboration, joint ventures, and tech integration efforts.

Technology-Driven Operations Utilizing advanced platforms such as SuccessFactors, AVEVA, and Amazon ALB highlights their focus on digital transformation, presenting potential for B2B tech solutions, software integrations, and process optimization services.

Similar companies to Lundbeck

Lundbeck Tech Stack

Lundbeck uses 8 technology products and services including Hotjar, Autodesk Revit, SuccessFactors, and more. Explore Lundbeck's tech stack below.

  • Hotjar
    Analytics
  • Autodesk Revit
    Cad & Graphics
  • SuccessFactors
    Human Resource Management System
  • Amazon ALB
    Load Balancers
  • Office 365
    Office Suites
  • Windows 10
    Operating Systems
  • AVEVA
    Operations
  • Vimeo
    Video Players

Media & News

Lundbeck's Email Address Formats

Lundbeck uses at least 1 format(s):
Lundbeck Email FormatsExamplePercentage
FLast@lundbeck.comJDoe@lundbeck.com
70%
First.Last@lundbeck.comJohn.Doe@lundbeck.com
17%
Last.F@lundbeck.comDoe.J@lundbeck.com
8%
Last@lundbeck.comDoe@lundbeck.com
5%

Frequently Asked Questions

Where is Lundbeck's headquarters located?

Minus sign iconPlus sign icon
Lundbeck's main headquarters is located at 9 Ottiliavej Copenhagen, Hovedstaden 2500 Denmark. The company has employees across 6 continents, including EuropeNorth AmericaAsia.

What is Lundbeck's stock symbol?

Minus sign iconPlus sign icon
Lundbeck is a publicly traded company; the company's stock symbol is LUN.CO.

What is Lundbeck's official website and social media links?

Minus sign iconPlus sign icon
Lundbeck's official website is lundbeck.com and has social profiles on LinkedInCrunchbase.

How much revenue does Lundbeck generate?

Minus sign iconPlus sign icon
As of February 2026, Lundbeck's annual revenue is estimated to be $5B.

What is Lundbeck's SIC code NAICS code?

Minus sign iconPlus sign icon
Lundbeck's SIC code is 2835 - In Vitro and In Vivo Diagnostic Substances NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Lundbeck have currently?

Minus sign iconPlus sign icon
As of February 2026, Lundbeck has approximately 6K employees across 6 continents, including EuropeNorth AmericaAsia. Key team members include Cio - Senior Vice President: C. T.Chief Commercial Officer: S. M.Vice President Commercial Excellence: E. C. M.. Explore Lundbeck's employee directory with LeadIQ.

What industry does Lundbeck belong to?

Minus sign iconPlus sign icon
Lundbeck operates in the Pharmaceutical Manufacturing industry.

What technology does Lundbeck use?

Minus sign iconPlus sign icon
Lundbeck's tech stack includes HotjarAutodesk RevitSuccessFactorsAmazon ALBOffice 365Windows 10AVEVAVimeo.

What is Lundbeck's email format?

Minus sign iconPlus sign icon
Lundbeck's email format typically follows the pattern of FLast@lundbeck.com. Find more Lundbeck email formats with LeadIQ.

How much funding has Lundbeck raised to date?

Minus sign iconPlus sign icon
As of February 2026, Lundbeck has raised $566M in funding. The last funding round occurred on May 22, 2025 for $566M.

When was Lundbeck founded?

Minus sign iconPlus sign icon
Lundbeck was founded in 1915.

Lundbeck

Pharmaceutical ManufacturingHovedstaden, Denmark5001-10000 Employees

Lundbeck is a biopharmaceutical company focusing exclusively on brain health. With more than 70 years of experience in neuroscience, we are committed to improving the lives of people with neurological and psychiatric diseases.

Brain disorders affect a large part of the world’s population, and the effects are felt throughout society. With the rapidly improving understanding of the biology of the brain, we hold ourselves accountable for advancing brain health by curiously exploring new opportunities for treatments.

As a focused innovator, we strive for our research and development programs to tackle some of the most complex neurological challenges. We develop transformative medicines targeting people for whom there are few or no treatments available, expanding into neuro-specialty and neuro-rare from our strong legacy within psychiatry and neurology.

We are committed to fighting stigma and we act to improve health equity. We strive to create long term value for our shareholders by making a positive contribution to patients, their families and society as a whole.

Lundbeck has more than 5,000 employees in more than 20 countries and our products are available in more than 80 countries. 

For additional information, we encourage you to visit our corporate site www.lundbeck.com

Section iconCompany Overview

Headquarters
9 Ottiliavej Copenhagen, Hovedstaden 2500 Denmark
SIC Code
2835 - In Vitro and In Vivo Diagnostic Substances
Stock Symbol
LUN.CO
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1915
Employees
5001-10000

Section iconFunding & Financials

  • $566M

    Lundbeck has raised a total of $566M of funding over 2 rounds. Their latest funding round was raised on May 22, 2025 in the amount of $566M.

  • $1B$10B

    Lundbeck's revenue is estimated to be in the range of $1B$10B

Section iconFunding & Financials

  • $566M

    Lundbeck has raised a total of $566M of funding over 2 rounds. Their latest funding round was raised on May 22, 2025 in the amount of $566M.

  • $1B$10B

    Lundbeck's revenue is estimated to be in the range of $1B$10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.